The role of occupational Aspergillus exposure in the development of diseases.

Aspergillus indoor exposure, fungal occupational exposure, Aspergillus-associated diseases, resistance, exposure assessment

Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
01 Apr 2019
Historique:
accepted: 06 09 2018
received: 02 05 2018
revised: 19 07 2018
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 26 3 2019
Statut: ppublish

Résumé

Aspergillus spp. have a high nutritional versatility and good growth on a large variety of construction materials. They also colonize soil or food, but decaying vegetation is their primary ecological niche. Therefore, exposure to fungi may occur at home, during hospitalization, during specific leisure activities, or at the workplace. The development of Aspergillus infections depends on the interplay between host susceptibility and the organism. Environments with high counts of fungal elements (conidia, hyphal fragments and others), high levels of bioarerosols, and elevated concentrations of mycotoxins or other volatile organic compounds should be considered as potential hazards, since they may present a risk to the exposed person. Rural tasks as well as work related to wood and food industries, poultries, swineries, waste handling plants, and other occupational environments involving contaminated organic material are among the ones posing higher respiratory risks to the workers. This paper presents a review of several studies related to occupational and indoor exposure to Aspergillus, potential health effects related to that exposure, and associated exposure assessment procedures.

Identifiants

pubmed: 30816970
pii: 5366897
doi: 10.1093/mmy/myy090
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S196-S205

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Raquel Sabino (R)

Nacional Institute of Health Dr. Ricardo Jorge - URSZ- Infectious Diseases Department, Lisbon, Portugal.
Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa.

Cristina Veríssimo (C)

Nacional Institute of Health Dr. Ricardo Jorge - URSZ- Infectious Diseases Department, Lisbon, Portugal.

Carla Viegas (C)

H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa.
Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa.

Susana Viegas (S)

H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa.
Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa.

João Brandão (J)

Nacional Institute of Health Dr. Ricardo Jorge - Department of Environmental Health, Lisbon, Portugal.

Magna Alves-Correia (M)

Allergy Unit, CUF Descobertas Hospital, Lisbon.

Luís-Miguel Borrego (LM)

Allergy Unit, CUF Descobertas Hospital, Lisbon.
The Chronic Diseases Research Center, CEDOC, NOVA Medical School / Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.

Karl V Clemons (KV)

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, United States.
California Institute for Medical Research, San Jose, California, United States.

David A Stevens (DA)

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, United States.
California Institute for Medical Research, San Jose, California, United States.

Malcolm Richardson (M)

Mycology Reference Centre, Manchester University NHS Foundation Trust.
Division of Infection, Immunity and Respiratory Medicine, University of Manchester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH